Smoking Cessation After Acute Coronary Syndrome

• Status: Completed
• Trial end date: 2019-12-30
• Target enrollment: 0
• Participant gender: Male

Summary

A randomized controlled trial was conducted in cardiology department and smoking cessation center of University Hospital of Monastir (Tunisia). All smokers Hospitalized for ACS were included. Participants were randomly assigned to either group "A", initiating Nicotine replacement therapy (NRT) in intra-hospitalization or a control group "B" that received NRT after hospital discharge. The end point assessment was smoking abstinence at 24 weeks following randomization, defined as self-reported abstinence in the past week before the 24 week clinic visit confirmed by a measured exhaled carbon monoxide ≤8 ppm. Data were analyzed by intention to treat.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Monastir
• Treatments: Nicotine

Criteria

Inclusion Criteria:

• patients aged more than 18 years, hospitalized with an ACS actively smoking at the time of inclusion, motivated to quit smoking, able to provide informed consent and willing to participate in a clinical study including a follow-up examination every 2 weeks after hospital discharge.

Exclusion Criteria:

• the refusal of assistance of smoking cessation, inability to follow-up clinical visit (professional, regional or physical hindrance), diagnosis of depression or of serious health condition at admission (ventilated patient, cardiogenic shock, etc).